Actuate Therapeutics Inc Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold00000000
Gross Profit00000000
R&D Expenses2.6M2.1M2.2M2.8M3.2M3.7M3.8M4.4M
Operating Expenses5.7M4.7M5.5M6.0M6.4M6.6M5.4M5.4M
Operating Income-5.7M-4.7M-5.5M-6.0M-6.4M-6.6M-5.4M-5.4M
Other Income / Gains80K135K65K19K49K113K-578K-1.1M
Net Income-5.6M-4.6M-5.4M-5.9M-6.3M-6.4M-6.0M-6.6M
EPS (Diluted)-0.24-0.20-0.25-0.30-0.32-0.60-0.55-0.34
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses3.1M03.3M3.2M3.1M2.9M1.6M1.1M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses3.1M2.6M3.3M3.2M3.1M2.9M1.6M1.1M
Other Expenses00000000
Cost And Expenses5.7M4.7M5.5M6.0M6.4M6.6M5.4M5.4M
Interest Income85K140K70K25K54K118K81K9K
Interest Expense5K5K5K5K5K5K3K5K
Depreciation And Amortization00000118K00
Ebitda-5.6M-4.5M-5.4M-5.9M-6.3M-6.3M-6.0M-6.6M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-5.6M-4.6M-5.4M-5.9M-6.3M-6.4M-6.0M-6.6M
Income Before Tax Ratio00000000
Income Tax Expense0800.00000000
Net Income Ratio00000000
Epsdiluted-0.24-0.20-0.25-0.30-0.32-0.60-0.55-0.34
Weighted Average Shs Out23.5M23.2M21.4M19.6M19.5M19.5M19.5M19.5M
Weighted Average Shs Out Dil23.5M23.2M21.4M19.6M19.5M19.5M19.5M19.5M